Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Artificial intelligence (AI)-based decision support improves reproducibility of tumor response assessment in neuro-oncology: An international multi-reader study.
Vollmuth P, Foltyn M, Huang RY, Galldiks N, Petersen J, Isensee F, van den Bent MJ, Barkhof F, Park JE, Park YW, Ahn SS, Brugnara G, Meredig H, Jain R, Smits M, Pope WB, Maier-Hein K, Weller M, Wen PY, Wick W, Bendszus M. Vollmuth P, et al. Among authors: isensee f. Neuro Oncol. 2023 Mar 14;25(3):533-543. doi: 10.1093/neuonc/noac189. Neuro Oncol. 2023. PMID: 35917833 Free PMC article.
USE-Evaluator: Performance metrics for medical image segmentation models supervised by uncertain, small or empty reference annotations in neuroimaging.
Ostmeier S, Axelrod B, Isensee F, Bertels J, Mlynash M, Christensen S, Lansberg MG, Albers GW, Sheth R, Verhaaren BFJ, Mahammedi A, Li LJ, Zaharchuk G, Heit JJ. Ostmeier S, et al. Among authors: isensee f. Med Image Anal. 2023 Dec;90:102927. doi: 10.1016/j.media.2023.102927. Epub 2023 Aug 10. Med Image Anal. 2023. PMID: 37672900
Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study.
Kickingereder P, Isensee F, Tursunova I, Petersen J, Neuberger U, Bonekamp D, Brugnara G, Schell M, Kessler T, Foltyn M, Harting I, Sahm F, Prager M, Nowosielski M, Wick A, Nolden M, Radbruch A, Debus J, Schlemmer HP, Heiland S, Platten M, von Deimling A, van den Bent MJ, Gorlia T, Wick W, Bendszus M, Maier-Hein KH. Kickingereder P, et al. Among authors: isensee f. Lancet Oncol. 2019 May;20(5):728-740. doi: 10.1016/S1470-2045(19)30098-1. Epub 2019 Apr 2. Lancet Oncol. 2019. PMID: 30952559
Automated brain extraction of multisequence MRI using artificial neural networks.
Isensee F, Schell M, Pflueger I, Brugnara G, Bonekamp D, Neuberger U, Wick A, Schlemmer HP, Heiland S, Wick W, Bendszus M, Maier-Hein KH, Kickingereder P. Isensee F, et al. Hum Brain Mapp. 2019 Dec 1;40(17):4952-4964. doi: 10.1002/hbm.24750. Epub 2019 Aug 12. Hum Brain Mapp. 2019. PMID: 31403237 Free PMC article.
Automated volumetric assessment with artificial neural networks might enable a more accurate assessment of disease burden in patients with multiple sclerosis.
Brugnara G, Isensee F, Neuberger U, Bonekamp D, Petersen J, Diem R, Wildemann B, Heiland S, Wick W, Bendszus M, Maier-Hein K, Kickingereder P. Brugnara G, et al. Among authors: isensee f. Eur Radiol. 2020 Apr;30(4):2356-2364. doi: 10.1007/s00330-019-06593-y. Epub 2020 Jan 3. Eur Radiol. 2020. PMID: 31900702
Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial.
Schell M, Pflüger I, Brugnara G, Isensee F, Neuberger U, Foltyn M, Kessler T, Sahm F, Wick A, Nowosielski M, Heiland S, Weller M, Platten M, Maier-Hein KH, Von Deimling A, Van Den Bent MJ, Gorlia T, Wick W, Bendszus M, Kickingereder P. Schell M, et al. Among authors: isensee f. Neuro Oncol. 2020 Nov 26;22(11):1667-1676. doi: 10.1093/neuonc/noaa120. Neuro Oncol. 2020. PMID: 32393964 Free PMC article. Clinical Trial.
Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial.
Kickingereder P, Brugnara G, Hansen MB, Nowosielski M, Pflüger I, Schell M, Isensee F, Foltyn M, Neuberger U, Kessler T, Sahm F, Wick A, Heiland S, Weller M, Platten M, von Deimling A, Maier-Hein KH, Østergaard L, van den Bent MJ, Gorlia T, Wick W, Bendszus M. Kickingereder P, et al. Among authors: isensee f. Radiology. 2020 Oct;297(1):164-175. doi: 10.1148/radiol.2020200978. Epub 2020 Jul 28. Radiology. 2020. PMID: 32720870 Clinical Trial.
44 results